Biopharma company faces pressure to trim costs and maximize value for shareholders


Hiraman | E+ | Getty Images

Company: Alkermes Plc (ALKS)

Business: Alkermes is a biopharmaceutical company that researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA (aripiprazole lauroxil), an extended-release intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL (naltrexone for extended-release injectable suspension) for the treatment of alcohol and opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia…


The Federal Reserve’s so-called taper talk could keep markets on edge through the summer

Previous article

Everything we know so far

Next article

You may also like

Leave a Reply

Notify of

More in Investing